The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2020-01-31
- Target Recruit Count
- 50
- Registration Number
- NCT02523924
- Locations
- 🇺🇸
SKCCC, Baltimore, Maryland, United States
Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer
- Conditions
- Hormone-Resistant Prostate CancerMetastatic Prostate CarcinomaStage IV Prostate Cancer
- Interventions
- Dietary Supplement: Ascorbic AcidOther: Laboratory Biomarker AnalysisOther: Pharmacological StudyOther: PlaceboOther: Quality-of-Life Assessment
- First Posted Date
- 2015-08-06
- Last Posted Date
- 2023-06-07
- Target Recruit Count
- 50
- Registration Number
- NCT02516670
- Locations
- 🇺🇸
Anne Arundel Health System, Research Institute, Annapolis, Maryland, United States
🇺🇸University Hospitals of Cleveland Seidman Cancer Center, Cleveland, Ohio, United States
🇺🇸Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2015-07-30
- Last Posted Date
- 2022-03-22
- Target Recruit Count
- 27
- Registration Number
- NCT02512172
- Locations
- 🇺🇸
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel
- Conditions
- Metastatic Prostate CarcinomaStage IV Prostate CancerHormone-Resistant Prostate CancerProstate Adenocarcinoma
- Interventions
- Other: Laboratory Biomarker AnalysisOther: Quality-of-Life Assessment
- First Posted Date
- 2015-07-08
- Last Posted Date
- 2018-07-12
- Target Recruit Count
- 5
- Registration Number
- NCT02491411
- Locations
- 🇺🇸
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma
- First Posted Date
- 2015-07-07
- Last Posted Date
- 2017-09-13
- Target Recruit Count
- 5
- Registration Number
- NCT02490930
- Locations
- 🇺🇸
The Johns Hopkins University, Baltimore, Maryland, United States
Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer
- Conditions
- Stage IV Prostate Cancer
- Interventions
- First Posted Date
- 2015-07-03
- Last Posted Date
- 2021-11-12
- Target Recruit Count
- 12
- Registration Number
- NCT02489357
- Locations
- 🇺🇸
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
Utilizing Advance Care Planning Videos to Empower Perioperative Cancer Patients and Families
- Conditions
- Cancer
- Interventions
- Behavioral: Control videoBehavioral: Advance care planning video
- First Posted Date
- 2015-07-03
- Last Posted Date
- 2017-08-29
- Target Recruit Count
- 92
- Registration Number
- NCT02489799
- Locations
- 🇺🇸
The Johns Hopkins Hospital, Baltimore, Maryland, United States
Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)
- Conditions
- Primary Peritoneal Carcinoma
- Interventions
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2021-04-12
- Target Recruit Count
- 24
- Registration Number
- NCT02485990
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2015-06-23
- Last Posted Date
- 2019-01-18
- Target Recruit Count
- 3
- Registration Number
- NCT02478125
- Locations
- 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC
- First Posted Date
- 2015-06-04
- Last Posted Date
- 2021-07-08
- Target Recruit Count
- 36
- Registration Number
- NCT02463799
- Locations
- 🇺🇸
Sibley Memorial Hospital, Washington, District of Columbia, United States
🇺🇸Tulane Cancer Center, New Orleans, Louisiana, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States